BioCentury
ARTICLE | Company News

HepaLife Technologies, U.S. Department of Agriculture deal

October 6, 2008 7:00 AM UTC

The parties expanded a 2007 deal that granted HepaLife exclusive rights to the USDA's PICM-19 hepatocyte cell lines to develop and commercialize artificial liver devices and in vitro toxicological tes...